| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Research Institute of Public Health and the Department of Public
Health and General Practice, University of Kuopio, and the Department of
Clinical Chemistry, Kuopio University Hospital (K.P.), Finland.
Correspondence to Professor Jukka T. Salonen, Research Institute of Public Health, University of Kuopio, Harjulantie 1B, 70210 Kuopio, Finland or PO Box 1627, 70211 Kuopio, Finland. E-mail salonen{at}reivi.uku.fi
Background—Epidemiological evidence
concerning the role of iron, a lipid peroxidation catalyst, in
coronary heart disease (CHD) is inconsistent. We
investigated the association of the concentration ratio of serum
transferrin receptor to serum ferritin (TfR/ferritin), a
state-of-the-art measurement of body iron stores, with the risk of
acute myocardial infarction (AMI) in a prospective nested case-control
study in men from eastern Finland.
Methods and Results—Transferrin receptor assays were carried out
for 99 men who had an AMI during an average 6.4 years of follow-up and
98 control men. Both the cases and the controls were nested from the
Kuopio Ischemic Heart Disease Risk Factor Study (KIHD) cohort
of 1931 men who had no clinical CHD at the baseline study. The controls
were matched for age, examination year, and residence. AMIs were
registered prospectively. Soluble transferrin receptors were measured
by immunoenzymometric assay and ferritin concentration by
radioimmunoassay from frozen baseline serum samples. The mean
TfR/ferritin ratio was 15.1 (SE, 2.0) among cases and 21.3 (SE, 2.2)
among controls (P=.035 for difference). In logistic
regression models adjusting for other strongest risk factors for AMI
and indicators of inflammation and alcohol intake, men in the lowest
and second lowest thirds of the TfR/ferritin ratio had a 2.9-fold (95%
CI, 1.3 to 6.6, P=.011) and 2.0-fold (0.9 to 4.2,
P=.081) risk of AMI compared with men in the highest
third (P=.010 for trend).
Conclusions—These data show an association between increased body
iron stores and excess risk of AMI, confirming previous epidemiological
findings.
© 1998 American Heart Association, Inc.
Clinical Investigation and Reports
Association Between Body Iron Stores and the Risk of Acute Myocardial Infarction in Men
Key Words: coronary disease • diabetes mellitus • ferritin • myocardial infarction • population
This article has been cited by other articles:
 |
|
 |
|
  I. S. Vari, B. Balkau, A. Kettaneh, P. Andre, J. Tichet, F. Fumeron, E. Caces, M. Marre, B. Grandchamp, P. Ducimetiere, et al. Ferritin and Transferrin Are Associated With Metabolic Syndrome Abnormalities and Their Change Over Time in a General Population: Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR) Diabetes Care, July 1, 2007; 30(7): 1795 - 1801. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Swaminathan, V. A. Fonseca, M. G. Alam, and S. V. Shah The Role of Iron in Diabetes and Its Complications Diabetes Care, July 1, 2007; 30(7): 1926 - 1933. [Full Text] [PDF]
|
|
|
|
 |
|
 C E Wrede, R Buettner, L C Bollheimer, J Scholmerich, K-D Palitzsch, and C Hellerbrand Association between serum ferritin and the insulin resistance syndrome in a representative population Eur. J. Endocrinol., February 1, 2006; 154(2): 333 - 340. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Emdin, A. Pompella, and A. Paolicchi Gamma-Glutamyltransferase, Atherosclerosis, and Cardiovascular Disease: Triggering Oxidative Stress Within the Plaque Circulation, October 4, 2005; 112(14): 2078 - 2080. [Full Text] [PDF]
|
|
|
|
 |
|
 A. T. Chan, J. Ma, G. J. Tranah, E. L. Giovannucci, N. Rifai, D. J. Hunter, and C. S. Fuchs Hemochromatosis Gene Mutations, Body Iron Stores, Dietary Iron, and Risk of Colorectal Adenoma in Women J Natl Cancer Inst, June 15, 2005; 97(12): 917 - 926. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. E.R. Kartikasari, N. A. Georgiou, F. L.J. Visseren, H. van Kats-Renaud, B. S. van Asbeck, and J. J.M. Marx Intracellular Labile Iron Modulates Adhesion of Human Monocytes to Human Endothelial Cells Arterioscler. Thromb. Vasc. Biol., December 1, 2004; 24(12): 2257 - 2262. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. N Singh, J. Sabate, and G. E Fraser Does low meat consumption increase life expectancy in humans? Am. J. Clinical Nutrition, September 1, 2003; 78(3): 526S - 532. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Ramakrishna, T. W Rooke, and L. T Cooper Iron and peripheral arterial disease: revisiting the iron hypothesis in a different light Vascular Medicine, August 1, 2003; 8(3): 203 - 210. [Abstract] [PDF]
|
|
|
|
 |
|
 M. W. Knuiman, M. L. Divitini, J. K. Olynyk, D. J. Cullen, and H. C. Bartholomew Serum Ferritin and Cardiovascular Disease: A 17-Year Follow-up Study in Busselton, Western Australia Am. J. Epidemiol., July 15, 2003; 158(2): 144 - 149. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Surber, H H Sigusch, H Kuehnert, and H R Figulla Haemochromatosis (HFE) gene C282Y mutation and the risk of coronary artery disease and myocardial infarction: a study in 1279 patients undergoing coronary angiography J. Med. Genet., May 1, 2003; 40(5): e58 - 58. [Full Text] [PDF]
|
|
|
|
 |
|
 S.-A. You, S. R. Archacki, G. Angheloiu, C. S. Moravec, S. Rao, M. Kinter, E. J. Topol, and Q. Wang Proteomic approach to coronary atherosclerosis shows ferritin light chain as a significant marker: evidence consistent with iron hypothesis in atherosclerosis Physiol Genomics, March 18, 2003; 13(1): 25 - 30. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J Fleming, K. L Tucker, P. F Jacques, G. E Dallal, P. W. Wilson, and R. J Wood Dietary factors associated with the risk of high iron stores in the elderly Framingham Heart Study cohort Am. J. Clinical Nutrition, December 1, 2002; 76(6): 1375 - 1384. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Schumann, B. Borch-Iohnsen, M. W Hentze, and J. J. Marx Tolerable upper intakes for dietary iron set by the US Food and Nutrition Board Am. J. Clinical Nutrition, September 1, 2002; 76(3): 499 - 500. [Full Text] [PDF]
|
|
|
|
|
|
D. J. A. Jenkins, C. W. C. Kendall, L. S. A. Augustin, M. C. Martini, M. Axelsen, D. Faulkner, E. Vidgen, T. Parker, H. Lau, P. W. Connelly, et al. Effect of Wheat Bran on Glycemic Control and Risk Factors for Cardiovascular Disease in Type 2 Diabetes Diabetes Care, September 1, 2002; 25(9): 1522 - 1528. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Kletzmayr, G. Sunder-Plassmann, and W. H. Horl High dose intravenous iron: a note of caution Nephrol. Dial. Transplant., June 1, 2002; 17(6): 962 - 965. [Full Text] [PDF]
|
|
|
|
 |
|
 M Emdin, C Passino, C Michelassi, F Titta, A L'abbate, L Donato, A Pompella, and A Paolicchi Prognostic value of serum gamma-glutamyl transferase activity after myocardial infarction Eur. Heart J., October 1, 2001; 22(19): 1802 - 1807. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Haidari, E. Javadi, A. Sanati, M. Hajilooi, and J. Ghanbili Association of Increased Ferritin with Premature Coronary Stenosis in Men Clin. Chem., September 1, 2001; 47(9): 1666 - 1672. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J Fleming, P. F Jacques, K. L Tucker, J. M Massaro, R. B D'Agostino Sr, P. W. Wilson, and R. J Wood Iron status of the free-living, elderly Framingham Heart Study cohort: an iron-replete population with a high prevalence of elevated iron stores Am. J. Clinical Nutrition, March 1, 2001; 73(3): 638 - 646. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Ascherio, E. B. Rimm, E. Giovannucci, W. C. Willett, and M. J. Stampfer Blood Donations and Risk of Coronary Heart Disease in Men Circulation, January 2, 2001; 103(1): 52 - 57. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Santos, M. de Sousa, L. H. P. M. Rademakers, H. Clevers, J. J. M. Marx, and M. W. Schilham Iron Overload and Heart Fibrosis in Mice Deficient for Both {beta}2-Microglobulin and Rag1 Am. J. Pathol., December 1, 2000; 157(6): 1883 - 1892. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Langlois, M.-E. Martin, J. R. Boelaert, C. Beaumont, Y. E. Taes, M. L. De Buyzere, D. R. Bernard, H. M. Neels, and J. R. Delanghe The Haptoglobin 2-2 Phenotype Affects Serum Markers of Iron Status in Healthy Males Clin. Chem., October 1, 2000; 46(10): 1619 - 1625. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Breuer, A. Ronson, I. N. Slotki, A. Abramov, C. Hershko, and Z. I. Cabantchik The assessment of serum nontransferrin-bound iron in chelation therapy and iron supplementation Blood, May 1, 2000; 95(9): 2975 - 2982. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Garry, W. C. Hunt, and R. N. Baumgartner Effects of Iron Intake on Iron Stores in Elderly Men and Women: Longitudinal and Cross-Sectional Results J. Am. Coll. Nutr., April 1, 2000; 19(2): 262 - 269. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Sullivan Iron and the Genetics of Cardiovascular Disease Circulation, September 21, 1999; 100(12): 1260 - 1263. [Full Text] [PDF]
|
|
|
|
|
|
T.-P. Tuomainen, K. Kontula, K. Nyyssonen, T. A. Lakka, T. Helio, and J. T. Salonen Increased Risk of Acute Myocardial Infarction in Carriers of the Hemochromatosis Gene Cys282Tyr Mutation : A Prospective Cohort Study in Men in Eastern Finland Circulation, September 21, 1999; 100(12): 1274 - 1279. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. DO, T.-P. Tuomainen, K. Nyyssonen, J. T. Salonen, and K. Punnonen Body Iron Stores, Infection, and Risk of Acute Myocardial Infarction • Response Circulation, July 27, 1999; 100(4): 446 - 449. [Full Text] [PDF]
|
|
|
|
 |
|
 B. de Valk and J. J. M. Marx Iron, Atherosclerosis, and Ischemic Heart Disease Arch Intern Med, July 26, 1999; 159(14): 1542 - 1548. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. T Salonen, T.-P. Tuomainen, K. Nyyssönen, H.-M. Lakka, and K. Punnonen Relation between iron stores and non-insulin dependent diabetes in men: case-control study BMJ, September 12, 1998; 317(7160): 727 - 730. [Full Text]
|
|